2-151490016-T-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001164508.2(NEB):āc.25359A>Cā(p.Gln8453His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,613,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001164508.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.25359A>C | p.Gln8453His | missense_variant | 181/182 | ENST00000427231.7 | NP_001157979.2 | |
NEB | NM_001164508.2 | c.25359A>C | p.Gln8453His | missense_variant | 181/182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.25359A>C | p.Gln8453His | missense_variant | 181/182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.25359A>C | p.Gln8453His | missense_variant | 181/182 | 5 | NM_001164507.2 | ENSP00000416578.2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248888Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134986
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461318Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726976
GnomAD4 genome AF: 0.000171 AC: 26AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74328
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.19791A>C (p.Q6597H) alteration is located in exon 149 (coding exon 147) of the NEB gene. This alteration results from a A to C substitution at nucleotide position 19791, causing the glutamine (Q) at amino acid position 6597 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
NEB-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 31, 2023 | The NEB c.25464A>C variant is predicted to result in the amino acid substitution p.Gln8488His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.033% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-152346530-T-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at